Dihydroxyacetone: A safe camouflaging option in vitiligo

International Journal of Dermatology

Volumn 47, Issue 4, 2008, Pages 402-406

  Rajatanavin, Natta ^a   Suwanachote, Suthida ^a   Kulkollakarn, Suthinee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYACETONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DATA COLLECTION METHOD; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ESTHETICS; FACE; FEMALE; FOOT; HAND; HUMAN; HUMAN EXPERIMENT; INTERVIEW; MALE; MEDICAL PHOTOGRAPHY; NORMAL HUMAN; PATIENT SATISFACTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN COLOR; SKIN EXAMINATION; TELEPHONE; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; CHILD; COSMETICS; DERMATOLOGIC AGENTS; DIHYDROXYACETONE; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SKIN; SKIN PIGMENTATION; VITILIGO;

EID: 41749114757     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03356.x     Document Type: Article

References (20)

1. Fesq H, Brockow K, Strom K, et.al. Dihydroxyacetone in a new formulation -a powerful therapeutic option in vitiligo. Dermatology 2001; 203: 241-243.
2. Roelandts R. Photo (chemo) therapy for vitiligo. Photodermatol Photoimmunol Photomed 2003; 19: 1-4.
3. Kent G, Al'Abadie M. Psychologic effects of vitiligo: A critical incident analysis. J Am Acad Dermatol 1996; 35: 895-898.
4. Porter JR, Beuf AH, Lerner AB, et.al. The effect of vitiligo on sexual relationships. J Am Acad Dermatol 1990; 22: 221-222.
5. Porter J, Beuf A, Nordlund JJ, et.al. Personal responses of patients to vitiligo: The importance of the patient-physician interaction. Arch Dermatol 1978; 114: 1384-1385.
6. Porter J, Beuf AH, Lerner A, et.al. Response to cosmetic disfigurement: patients with vitiligo. Cutis 1987; 39: 493-494.
7. Porter JR, Beuf AH, Lerner A, et.al. Psychosocial effect of vitiligo: A comparison of vitiligo patients with "normal"control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986; 15: 220-224.
8. Ongenae K, Dierckxsens L, Brochez L, et.al. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 2005; 210: 279-285.
9. Ongenae K, Van Geel N, De Schepper S, et.al. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005; 152: 1165-1172.
10. Njoo MD, Spuls PI, Bos JD, et.al. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998; 134: 1532-1540.
11. Natta R, Somsak T, Wisuttida T, et.al. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 2003; 49: 473-476.
12. Wittgenstein E, Guest GM. Biochemical effects of dihydroxyacetone. J Invest Dermatol 1961; 37: 421-426.
13. Levy SB. Tanning preparations. Dermatol Clin 2000; 18: 591-596.
14. Goldman L, Wittgenstein E, Blaney D, et.al. Studies of some physical properties of the dihydroxyacetone color complex. J Invest Dermatol 1961; 36: 233-234.
15. Suga Y, Ikejima A, Matsuba S, et.al. Medical pearl: DHA application for camouflaging segmental vitiligo and piebald lesions. J Am Acad Dermatol 2002; 47: 436-438.
16. Levy SB. Dihydroxyacetone-containing sunless or self-tanning lotions. J Am Acad Dermatol 1992; 27: 989-993.
17. Faurschou A, Wulf HC. Durability of the sun protection factor provided by dihydroxyacetone. Photodermatol Photoimmunol Photomed 2004; 20: 239-242.
18. Faurschou A, Janjua NR, Wulf HC. Sun protection effect of dihydroxyacetone. Arch Dermatol 2004; 140: 886-887.
19. Akin FJ, Marlowe E. Non-carcinogenicity of dihydroxyacetone by skin painting. J Environ Pathol Toxicol Oncol 1984; 5: 349-351.
20. Fu JM, Dusza SW, Halpern AC. Sunless tanning. J Am Acad Dermatol 2004; 50: 706-713.